ReviewTherapeutic delivery2010
Stem cells and regenerative medicine: accomplishments to date and future promise.
Review in Therapeutic delivery, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Synthetic alternatives to Matrigel.Nature reviews. Materials · 2020Article
- Attitude of A Sample of Iranian Researchers toward The Future of Stem Cell Research.Cell journal · 2018Article
- The effects of bone marrow-derived mesenchymal stem cells on ovalbumin-induced allergic asthma and cytokine responses in mice.Iranian journal of basic medical sciences · 2018Article
- Dynamics of Telomere Length and Telomerase Activity in the Human Fetal Liver at 5-12 Weeks of Gestation.Stem cells international · 2018Article
- C-X-C motif chemokine ligand 8 promotes endothelial cell homing via the Akt-signal transducer and activator of transcription pathway to accelerate healing of ischemic and hypoxic skin ulcers.Experimental and therapeutic medicine · 2017Article
- Supremacy of modern morphometry in typing renal oncocytoma and malignant look-alikes.Histochemistry and cell biology · 2015Article
- Comparison of mesenchymal stem cell markers in multiple human adult stem cells.International journal of stem cells · 2014Article
- Scientific Productivity on Research in Ethical Issues over the Past Half Century: A JoinPoint Regression Analysis.Tropical medicine and health · 2014Article
- TJournal of cancer stem cell research · 2014Article
- Pollen-induced antigen presentation by mesenchymal stem cells and T cells from allergic rhinitis.Clinical & translational immunology · 2013Article
- Cell-based strategies to reconstitute lung function in infants with severe bronchopulmonary dysplasia.Clinics in perinatology · 2012Review
- Developmental regulation of TAC1 in peptidergic-induced human mesenchymal stem cells: implication for spinal cord injury in zebrafish.Stem cells and development · 2012Article
- Directed induction of functional motor neuron-like cells from genetically engineered human mesenchymal stem cells.PloS one · 2012Article
- Science and ethics: bridge to the future for regenerative medicine.International journal of stem cells · 2011Review
- AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast cancer cells.American journal of cancer research · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
More than 50 years have passed since the first allogeneic hematopoietic stem cell transplant in patients; however, the promise of other stem cell populations for tissue replacement and repair remains unachieved. When considering cell-based interventions for personalized medicine, the factors influencing therapeutic success and safety are more complicated than for traditional small-molecule pharmacological agents and protein biologics. Failure to progress personalized stem cell therapies to the clinic has resulted from complications that include an incomplete understanding of developmental programs and the diversity of host-donor interactions. In order to more rapidly extend the use of stem cells to the clinic, a better understanding of the different stem cell sources and the implications of their host interactions is required. In this review, we introduce the currently available sources and highlight recent literature that instructs the potential and limitations of their use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.